Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Clinical Proteomics

Fig. 3

From: The serum protein responses to treatment with Xiaoke Pill and Glibenclamide in type 2 diabetes patients

Fig. 3

Cluster analysis of the abundance changes in the diabetic patient serum proteome in response to the Xiaoke Pill or Glibenclamide. a Cluster analysis of the abundance changes in serum proteins in response to T2DM with/without hypoglycemia without a drug treatment. b Cluster analysis of the abundance changes in serum proteins in response to the two different drug treatments

Back to article page